Rx/Reimbursement Adult Incontinence in France

Value sales of Rx/reimbursement adult incontinence increased in 2024 in France, as did volume sales. In France, these products sustained a positive growth trend over the year, driven by their essential nature, which makes them difficult to substitute. Demand stems largely from an ageing population and rising life expectancy, factors that particularly bolster moderate/heavy adult incontinence products over light alternatives.

The Rx/Reimbursement adult incontinence in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Rx/Reimbursement adult incontinence market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.